Literature DB >> 16197782

Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels.

Edward Ram1, Tali Vishne, Dror Diker, Irit Gal-Ad, Rachel Maayan, Igor Lerner, Zeev Dreznik, Dan Seror, Pnina Vardi, Abraham Weizman.   

Abstract

BACKGROUND: Several endocrine abnormalities are reported in obesity. Some are considered as causative factors, whereas others are considered to be secondary effects of obesity. In the current study, we explored the changes in cortisol, growth hormone (GH), DHEA, DHEA-S and GH releasing hormone (ghrelin) plasma levels in morbidly obese subjects who lost abundant weight following laparoscopic adjustable gastric banding (LAGB).
METHODS: 12 morbidly obese adult patients (15 females), age 21-56 years with BMI 46.0+/-4.4 kg/cm(2), were studied. Blood samples were collected before, 6 and 14 months after LAGB. The levels of DHEA, DHEA-S, cortisol, GH, and ghrelin were determined by commercial kits. Statistical analysis was based on one-way repeated measures ANOVA, followed by Student-Newman-Keuls post-hoc test.
RESULTS: Mean BMI reduced significantly along the study course (P=.000). Cortisol plasma levels significantly decreased 6 months after surgery (from 541.4+/-242.4 nM to 382.4+/-142.1 nM, P=.004), but did not change further after 14 months (460.2+/-244.9 nM), despite further reduction in BMI (P=.050). GH constantly increased throughout the study from 0.076+/-0.149 ng/ml, to 0.410+/-0.509 ng/ml at 6 months (NS), to 1.224+/-1.738 ng/ml at 14 months after surgery (P=.001). DHEA, DHEA-S and ghrelin plasma levels remained stable throughout the study.
CONCLUSIONS: GH levels showed a persistent increase during the 14 months following LAGB in association with the weight loss, while a transient decrease in cortisol levels occurred at the 6-months time-point. In contrast, ghrelin, DHEA and DHEA-S were not altered after surgery. The association between GH and cortisol secretion and surgical- and nonsurgical-induced weight reduction merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197782     DOI: 10.1381/0960892055002329

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  10 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

Review 2.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

Review 3.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

Review 4.  Changes in ghrelin levels following bariatric surgery: review of the literature.

Authors:  Kevin Tymitz; Amy Engel; Sarah McDonough; Mary Pat Hendy; George Kerlakian
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

5.  Hypogonadotropic hypogonadism in a patient with morbid obesity.

Authors:  Miguel Angel Mollar Puchades; Rosa Cámara Gómez; Maria Isabel del Olmo García; José Luis Ponce Marco; Raquel Segovia Portolés; Pablo Abellán Galiana; Francisco Piñón Sellés
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

Review 6.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

Review 7.  Pathophysiology of obesity: why surgery remains the most effective treatment.

Authors:  Talat Waseem; Kris M Mogensen; David B Lautz; Malcolm K Robinson
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

8.  Increase in ghrelin levels after weight loss in obese Zucker rats is prevented by gastric banding.

Authors:  Mariana P Monteiro; Andreia H Ribeiro; Ana F Nunes; Mónica M Sousa; J Duarte Monteiro; Artur P Aguas; M Helena Cardoso
Journal:  Obes Surg       Date:  2007-11-30       Impact factor: 4.129

Review 9.  The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective.

Authors:  Jéssica Aparecida da Silva Pereira; Felipe Corrêa da Silva; Pedro Manoel Mendes de Moraes-Vieira
Journal:  J Diabetes Res       Date:  2017-09-07       Impact factor: 4.011

10.  Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients.

Authors:  Bernard Uzzan; Jean-Marc Catheline; Christine Lagorce; Gheorghe Airinei; Cyriaque Bon; Régis Cohen; Gérard-Yves Perret; Thomas Aparicio; Robert Benamouzig
Journal:  Obes Surg       Date:  2007-09       Impact factor: 3.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.